NorOxymorphone , 98% , 33522-95-1

CAS NO.：33522-95-1

Empirical Formula: C16H17NO4

Molecular Weight: 287.32

MDL number: MFCD00058530

EINECS: 251-561-5

PRODUCT Properties

• Melting point: >265°C (dec.)
• Boiling point: 552.1±50.0 °C(Predicted)
• Density: 1.54±0.1 g/cm3(Predicted)
• Flash point: 22℃
• storage temp.: Controlled Substance, -20°C Freezer
• solubility: DMF: 20 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 10 mg/ml
• form: A crystalline solid
• pka: 9.20±0.40(Predicted)
• Stability: Hygroscopic
• InChI: InChI=1/C16H17NO4/c18-9-2-1-8-7-11-16(20)4-3-10(19)14-15(16,5-6-17-11)12(8)13(9)21-14/h1-2,11,14,17-18,20H,3-7H2/t11-,14+,15+,16-/s3
• InChIKey: HLMSIZPQBSYUNL-RSBMUYHFNA-N
• SMILES: O[C@]12CCC(=O)[C@]3([H])OC4=C(C=CC5C[C@@]1([H])NCC[C@@]23C4=5)O |&1:1,6,15,20,r|

Description and Uses

Noroxymorphone (Item No. 15903) is an analytical reference standard that is structurally categorized as an opioid. It is an active metabolite of oxycodone , noroxycodone (Item Nos. 15902 | 20407), and oxymorphone that can be detected in plasma and urine. Noroxymorphone is also an immediate precursor in the synthesis of several opioids, including naltrexone (Item Nos. 15520 | ISO60192) and naloxone (Item Nos. 15594 | ISO60191). Noroxymorphone is regulated as a Schedule II compound in the United States. This product is intended for research and forensic applications.

A metabolite of Naloxone and Naltrexone

Safety

• Symbol(GHS): GHS02,GHS06,GHS08
• Signal word: Danger
• Hazard statements: H225-H301+H311+H331-H370
• Precautionary statements: P210-P260-P280-P301+P310-P311
• Hazard Codes: T,F
• Risk Statements: 10-23/24/25-39/23/24/25-11
• Safety Statements: 36/37-45-16-7
• RIDADR: UN1230 - class 3 - PG 2 - Methanol, solution
• WGK Germany: 1
• DEA Controlled Substances: CSCN: 9668; CSA SCH: Schedule II; NARC: Yes